Login / Signup
Mary Varterasian
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Escherichia Coli
Combination Therapy
Social Media
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jason John Luke
,
Sarina A Piha-Paul
,
Theresa M Medina
,
Claire F Verschraegen
,
Mary Varterasian
,
Aoife M Brennan
,
Richard J Riese
,
Anna Sokolovska
,
James F Strauss
,
David L Hava
,
Filip Janku
Phase I study of SYNB1891, an engineered E coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Jason John Luke
,
Sarina A Piha-Paul
,
Theresa M Medina
,
Claire F Verschraegen
,
Mary Varterasian
,
Aoife M Brennan
,
Richard J Riese
,
Anna Sokolovska
,
James F Strauss
,
David L Hava
,
Filip Janku
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)